针刺用于剖宫产术后镇痛的效果:一项随机临床试验
这项单中心、安慰剂对照、患者与评估者盲法的随机临床试验于2015年1月13日至2018年6月27日在德国格赖夫斯瓦尔德一家三级大学医院进行,纳入择期蛛网膜下腔麻醉剖宫产产妇,随机分为针刺组(n=60)和安慰剂组(n=60),另选60例符合条件接受标准术后镇痛者作为非随机标准治疗组。针刺组在标准镇痛基础上加用耳穴和体穴针刺留置皮内针。术后第1天活动痛针刺组4.7(1.8)分,低于安慰剂组6.0(2.0)分(Cohen d 0.73,95%CI 0.31-1.01,P=.001)和标准治疗组6.3(1.3)分(Cohen d 1.01,95%CI 0.63-1.40,P<.001)。结论认为针刺安全有效,考虑人力与时间成本,可推荐作为择期剖宫产术后镇痛的常规补充治疗。
要点
- 术后第1天活动痛针刺组4.7(1.8)分,低于安慰剂组6.0(2.0)分(Cohen d 0.73,95%CI 0.31-1.01,P=.001)。
- 术后第1天活动痛针刺组4.7(1.8)分,低于标准治疗组6.3(1.3)分(Cohen d 1.01,95%CI 0.63-1.40,P<.001)。
- 术后第1天完全下床活动针刺组59例(98%)vs 安慰剂组49例(83%)(RR 1.18,95%CI 1.06-1.33,P=.01),vs 标准治疗组35例(58%)(RR 1.69,95%CI 1.36-2.09,P<.001)。
- 导尿管拔除针刺组57例(93%)vs 安慰剂组43例(72%)(RR 1.33,95%CI 1.12-1.57,P=.003),vs 标准治疗组42例(70%)(RR 1.37,95%CI 1.14-1.62,P=.002)。
- 作者认为,考虑人力与时间成本,针刺可作为择期剖宫产术后镇痛的常规补充治疗。
适用人群与场景
- 德国格赖夫斯瓦尔德一家三级大学医院中计划在蛛网膜下腔麻醉下接受择期剖宫产的产妇。
- 随机分组为针刺组(n=60)和安慰剂组(n=60);另选60例符合纳入标准并接受标准术后镇痛者组成非随机标准治疗组。
处置流程与药物剂量
- 针刺组在标准镇痛治疗基础上接受耳穴和体穴针刺,使用留置皮内针。
- 安慰剂组使用不穿透皮肤的安慰剂针。
研究设计与关键结果
- 单中心、安慰剂对照、患者与评估者盲法随机临床试验,2015年1月13日至2018年6月27日进行,共180例女性患者纳入意向性分析(平均[SD]年龄31[5]岁)。
- 主要终点术后第1天活动痛(11项口头评分量表):针刺组4.7(1.8)分 vs 安慰剂组6.0(2.0)分(Cohen d 0.73,95%CI 0.31-1.01,P=.001);针刺组 vs 标准治疗组6.3(1.3)分(Cohen d 1.01,95%CI 0.63-1.40,P<.001)。
- 术后第1天完全下床活动:针刺组59例(98%)vs 安慰剂组49例(83%)(RR 1.18,95%CI 1.06-1.33,P=.01);针刺组 vs 标准治疗组35例(58%)(RR 1.69,95%CI 1.36-2.09,P<.001)。
- 导尿管拔除:针刺组57例(93%)vs 安慰剂组43例(72%)(RR 1.33,95%CI 1.12-1.57,P=.003);针刺组 vs 标准治疗组42例(70%)(RR 1.37,95%CI 1.14-1.62,P=.002)。
- 其他参数在三组间相当。
证据类型、等级与局限
- 证据类型:单中心、安慰剂对照、患者与评估者盲法随机临床试验。
- 作者结论:针刺安全有效,可减轻剖宫产术后疼痛并加快患者下床活动。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,考虑人力与时间成本,针刺可推荐作为择期剖宫产术后镇痛的常规补充治疗。
- 该干预为在标准镇痛基础上加用耳穴和体穴针刺留置皮内针,安慰剂对照使用不穿透皮肤的安慰剂针。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: A pharmacological approach to pain control after cesarean delivery is often insufficient on its own. Acupuncture is a promising method for mitigating postoperative pain and reducing postoperative opioid requirements.
OBJECTIVE: To evaluate the efficacy and effectiveness of acupuncture as an adjunctive therapy for pain control after cesarean delivery, compared with a placebo intervention and standard care alone.
DESIGN, SETTING, AND PARTICIPANTS: This single-center, placebo-controlled, patient- and assessor-blinded randomized clinical trial was conducted from January 13, 2015, to June 27, 2018, at a tertiary university hospital in Greifswald, Germany. Participants were women who were scheduled for elective cesarean delivery under spinal anesthesia and were randomized to either the acupuncture group (n = 60) or placebo group (n = 60). Another 60 consecutive patients who met the eligibility criteria and received the standard postoperative analgesia were selected to form a nonrandomized standard care group. The intention-to-treat analysis was performed from August 19, 2019, to September 13, 2019.
INTERVENTIONS: In addition to standard pain treatment, each patient in the acupuncture group received auricular and body acupuncture with indwelling intradermal needles, whereas patients in the placebo group were treated with nonpenetrating placebo needles.
MAIN OUTCOMES AND MEASURES: The primary outcome was pain intensity on movement, which was measured using an 11-item verbal rating scale. Secondary outcomes were analgesia-related adverse effects, analgesics consumption, time to mobilization and Foley catheter removal, quality of patient blinding to randomization, and patient satisfaction with treatment of pain.
RESULTS: A total of 180 female patients (mean [SD] age, 31 [5] years) were included in the intention-to-treat analysis. The mean pain intensity on movement in the acupuncture group on the first postoperative day was lower than in the placebo group (4.7 [1.8] vs 6.0 [2.0] points; Cohen d, 0.73; 95% CI, 0.31-1.01; P = .001) and the standard care group (6.3 [1.3] points; Cohen d, 1.01; 95% CI, 0.63-1.40; P < .001). On the first postoperative day, 59 patients (98%) in the acupuncture group were fully mobilized vs 49 patients (83%) in the placebo group (relative risk [RR], 1.18; 95% CI, 1.06-1.33; P = .01) and 35 patients (58%) in the standard care group (RR, 1.69; 95% CI, 1.36-2.09; P < .001). The Foley catheter was removed in a total of 57 patients (93%) from the acupuncture group vs 43 patients (72%) from the placebo group (RR, 1.33; 95% CI, 1.12-1.57; P = .003) and 42 patients (70%) from the standard care group (RR, 1.37; 95% CI, 1.14-1.62; P = .002). Other parameters were comparable across the 3 study groups.
CONCLUSIONS AND RELEVANCE: Results of this trial showed that acupuncture was safe and effective in reducing pain and accelerating mobilization of patients after cesarean delivery. With consideration for personnel and time expenditures, acupuncture can be recommended as routine, supplemental therapy for pain control in patients after elective cesarean delivery.
TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02364167.
参考来源
- Usichenko TI, Henkel BJ, Klausenitz C, et al. Effectiveness of Acupuncture for Pain Control After Cesarean Delivery: A Randomized Clinical Trial. JAMA Netw Open. 2022. PMID: 35226080. doi:10.1001/jamanetworkopen.2022.0517
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。